Announced Tue, 16 Jun · 18:00 IST
Subsidiary TML private placement; parent stake dips to 58.67%
Fund Raising View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.6%1-day move
₹247.05
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+1.6-1.2-0.8+0.3-0.3+9.3+6.6+5.2——
Up moveDown movePending
AI summary
Trident Lifeline's subsidiary Trident Mediquip (TML) allotted equity shares via private placement to other shareholders, diluting the parent's stake from 58.84% to 58.67%. TML, in the medical device industry, reported turnover of Rs 27.31 Cr in FY26 vs Rs 21.29 Cr in FY25. The related-party transaction was carried out at arm's length.
Likely market impact
Minor dilution in a growing subsidiary (TML revenue up ~28% YoY); limited impact on consolidated financials and EPS.